Clinical Trials Browser

Phase 1 × Cholangiocarcinoma × Injections × Clear all

NCT04676633 2024-03-19

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma